Purchase Order 75D30120P09831
- Not listed
- The Department of Health and Human Services Centers for Disease Control and Prevention in Pittsburgh awarded a $90,000 firm fixed price purchase order to Roche Diagnostics Corporation. Under this contract, Roche will deliver MAGNA PURE 96 INSTRUMENTS to the CDC location in Castleton, Indiana by September 20, 2023 to support the agency's disease prevention and health promotion efforts. As one of the largest government contractors in the medical device sector, Roche will leverage existing...
- This is a $97,000.00 firm fixed price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, and laboratory equipment. The contract, titled "MAGNA 96", has an ultimate completion date of November 30, 2015 and does not have a set-aside designation. Roche Diagnostics has provided critical care analyzers, reagents, test kits, and associated laboratory equipment,...
- The Department of Health and Human Services Centers for Disease Control and Prevention in Pittsburgh awarded Roche Diagnostics Corporation a $53,105 purchase order contract to provide MAGNA PURE24 products. The contract has a firm fixed price and period of performance from September 19, 2023 through October 31, 2023. Place of performance will be Roche's facility in Castleton, Indiana. No subcontractors or set aside designations were identified. The CDC likely requires the MAGNA PURE24...
- The Department of Health and Human Services Centers for Disease Control and Prevention awarded a firm-fixed-price purchase order to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, for the delivery of MAGNA PURE 96 INSTRUMENTS. The contract, which has a potential value of $180,000.00, does not have a set-aside designation and has an anticipated completion date of April 15, 2022. Roche Diagnostics, a foreign-owned, for-profit manufacturer of in vitro diagnostics,...
- This $90,000.00 firm fixed price purchase order was awarded by the Centers for Disease Control and Prevention (CDC) to Roche Diagnostics Corporation for MAGNA PURE 96 products. The contract has no set-aside designation and has a completion date of July 23, 2022. Roche Diagnostics is a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. They have previously received prime contract and subcontract awards from various federal...
- This firm fixed-price purchase order contract was awarded by the Centers for Disease Control and Prevention (CDC) to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The contract is for the MAGNA PURE 96 INSTRUMENT IVD, with a ceiling value of $90,000.00 and a completion date of July 15, 2017. Roche Diagnostics has received numerous federal contract awards, including through its...
- This purchase order awards Roche Diagnostics Corporation $42,140 to supply MAGNA PURE 96 DNA AND VIRAL NA SMALL VOLUME KITS to the Centers for Disease Control and Prevention in Castleton, Indiana. Roche will deliver the kits by August 15, 2021 under the firm fixed price contract. No set-aside designation was used for this award placed against an existing IDC or BPA vehicle. As a leading manufacturer of in vitro diagnostics and laboratory equipment, Roche routinely supplies medical devices,...
- This is a $97,000.00 firm fixed price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The contract is for the acquisition of MAGNA PURE EQUIPMENT and does not have a set-aside designation. Roche Diagnostics has received multiple prime contract and subcontract awards from various federal agencies to provide...
- This is a firm fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, for the MAGNA PURE96 INSTRUMENT. The contract has a ceiling value of $91,563.00 and an ultimate completion date of August 31, 2017. The contract is not designated as a set-aside. Roche Diagnostics has provided critical care analyzers, reagents, test kits, and associated laboratory equipment, supplies, and services to...
- This federal contract award, with an ID of HHSD2002017M93189P, was made by the Centers for Disease Control and Prevention (CDC) to Roche Diagnostics Corporation for the procurement of a MAGNA PURE 96 INSTRUMENT WITH ACCESSORIES. The fixed-price contract has a ceiling value of $105,000.00 and an ultimate completion date of March 30, 2017. Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, is a manufacturer and distributor of in vitro diagnostics, reagents, laboratory...
Roche Diagnostics Corporation was awarded a firm fixed price purchase order by the Department of Health and Human Services Centers for Disease Control and Prevention Pittsburgh. The award, valued at two hundred thirty-seven thousand seven hundred forty-one dollars and sixty cents ($237,741.60), is for the product "MAGNA PURE 96" and has a completion date of October 15, 2020. The place of performance is Castleton, Indiana. No set-aside designation was used for this contract. Roche Diagnostics holds multiple General Services Administration schedules and indefinite delivery contracts through which federal agencies can acquire laboratory instruments, reagents, test kits, and associated products and services on an as-needed basis to support essential medical and public health functions.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Other Administrative Action | ($28k) | 2/29/24 | |
| Not listed | Not listed | $207.7k | 9/11/20 |